Search Results - Eva Venegas
- Showing 1 - 2 results of 2
-
1
Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets by Antonio C. Fuentes-Fayos, Miguel E. G-García, Teresa Sánchez-Medianero, John Apps, Álvaro Flores-Martínez, Ana S. De la Rosa-Herencia, Ignacio Gil-Duque, Georg Otto, Eva Venegas-Moreno, Eugenio Cárdenas Ruiz-Valdepeñas, Aura D. Herrera-Martínez, Juan Solivera, Manuel D. Gahete, David A. Cano, Rosa Ortega, Alfonso Soto-Moreno, María A. Gálvez-Moreno, Juan Pedro Martínez-Barberá, Raúl M. Luque
Published 2025-06-01Abstract Craniopharyngiomas are rare benign pathologies but clinically challenging tumours because of their intimate relationship with critical brain structures, leading to severe endocrine-deficiencies/comorbidities. Therefore, identifying alternative prognostic/therapeutic tools is crucial. Althou...
Get full text
Article -
2
Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas by Marta Araujo-Castro, Betina Biagetti, Edelmiro Menéndez, Iría Novoa-Testa, Fernando Cordido, Víctor Rodríguez Berrocal, Eider Pascual-Corrales, Fernando Guerrero-Pérez, Almudena Vicente, Rogelio García-Centeno, Laura González, María Dolores Ollero García, Ana Irigaray Echarri, María Dolores Moure Rodríguez, Cristina Novo-Rodríguez, María Calatayud, Rocío Villar-Taibo, Ignacio Bernabéu, Cristina Alvarez-Escola, Carmen Tenorio Jimenéz, Pablo Abellán-Galiana, Eva Venegas, Inmaculada González-Molero, Pedro Iglesias, Concepción Blanco, Fernando Vidal-Ostos De Lara, María Paz de Miguel Novoa, Elena López-Mezquita Torres, Felicia Hanzu, Cristina Lamas, Silvia Aznar Rodríguez, Anna Aulinas, José María Recio, María Dolores Aviles-Pérez, Miguel Antonio Sampedro Núñez, Rosa Camara, Miguel Paja Fano, Carmen Fajardo, Luís Cardoso, Pedro Marques, Elena Martínez-Sáez, Ignacio Ruz-Caracuel, Mónica Marazuela, Manel Puig-Domingo
Published 2025-07-01Aim: To evaluate which factors are associated with a higher probability of failure to surgical and first-generation somatostatin receptor ligands (fgSRLs) treatment in patients with growth hormone and prolactin co-secreting pituitary adenomas (GH&PRL-PAs). Methods: Acromegaly patients with GH&am...
Get full text
Article